Soluble interleukin 2 receptor levels in families of people with schizophrenia

Typeset version

 

TY  - JOUR
  - Gaughran, F.,O'Neill, E.,Sham, P.,Daly, R. J.,Shanahan, F.
  - 2002
  - August
  - Schizophrenia Research
  - Soluble interleukin 2 receptor levels in families of people with schizophrenia
  - Validated
  - ()
  - 56
  - 3
  - 235
  - 239
  - Background: Several authors have reported increased soluble interleukin 2 receptor (sIL2Ralpha) concentrations in schizophrenia. The aim of this work was to examine serum sIL2Ra in the first degree relatives of patients with schizophrenia. Methods: We sampled 51 first degree relatives of patients with DSM IIIR schizophrenia. These relatives were unaffected by psychosis and included nine fathers, thirteen mothers, seventeen sisters and twelve brothers. They were compared to 126 controls who were not pregnant, had no known autoimmune disorder and no intercurrent illness. Neither the controls, nor their first degree relatives, suffered from a psychotic illness. Serum sIL2Ralpha was analysed using a commercial ELISA preparation (Quantikine sIL2Ralpha immunoassay - R and D Systems, Inc.). We used non-parametric Mann Whitney U test and Spearman correlation throughout. SIL2Ralpha levels were adjusted for higher levels in females and with increasing age. Results: Adjusted mean sIL2Ra values of unaffected siblings, averaged within their families, were higher than controls (n = 14, one-tailed p = 0.027). There was no difference in sIL2Ralpha values between fathers or mothers and controls following regression for age and sex. Conclusion: Soluble interleukin 2 receptoralpha levels are increased in siblings of patients with schizophrenia. (C) 2002 Elsevier Science B.V. All rights reserved.Background: Several authors have reported increased soluble interleukin 2 receptor (sIL2Ralpha) concentrations in schizophrenia. The aim of this work was to examine serum sIL2Ra in the first degree relatives of patients with schizophrenia. Methods: We sampled 51 first degree relatives of patients with DSM IIIR schizophrenia. These relatives were unaffected by psychosis and included nine fathers, thirteen mothers, seventeen sisters and twelve brothers. They were compared to 126 controls who were not pregnant, had no known autoimmune disorder and no intercurrent illness. Neither the controls, nor their first degree relatives, suffered from a psychotic illness. Serum sIL2Ralpha was analysed using a commercial ELISA preparation (Quantikine sIL2Ralpha immunoassay - R and D Systems, Inc.). We used non-parametric Mann Whitney U test and Spearman correlation throughout. SIL2Ralpha levels were adjusted for higher levels in females and with increasing age. Results: Adjusted mean sIL2Ra values of unaffected siblings, averaged within their families, were higher than controls (n = 14, one-tailed p = 0.027). There was no difference in sIL2Ralpha values between fathers or mothers and controls following regression for age and sex. Conclusion: Soluble interleukin 2 receptoralpha levels are increased in siblings of patients with schizophrenia. (C) 2002 Elsevier Science B.V. All rights reserved.
  - 0920-99640920-9964
  - ://WOS:000176404300004://WOS:000176404300004
DA  - 2002/08
ER  - 
@article{V235379556,
   = {Gaughran,  F. and O'Neill,  E. and Sham,  P. and Daly,  R. J. and Shanahan,  F. },
   = {2002},
   = {August},
   = {Schizophrenia Research},
   = {Soluble interleukin 2 receptor levels in families of people with schizophrenia},
   = {Validated},
   = {()},
   = {56},
   = {3},
  pages = {235--239},
   = {{Background: Several authors have reported increased soluble interleukin 2 receptor (sIL2Ralpha) concentrations in schizophrenia. The aim of this work was to examine serum sIL2Ra in the first degree relatives of patients with schizophrenia. Methods: We sampled 51 first degree relatives of patients with DSM IIIR schizophrenia. These relatives were unaffected by psychosis and included nine fathers, thirteen mothers, seventeen sisters and twelve brothers. They were compared to 126 controls who were not pregnant, had no known autoimmune disorder and no intercurrent illness. Neither the controls, nor their first degree relatives, suffered from a psychotic illness. Serum sIL2Ralpha was analysed using a commercial ELISA preparation (Quantikine sIL2Ralpha immunoassay - R and D Systems, Inc.). We used non-parametric Mann Whitney U test and Spearman correlation throughout. SIL2Ralpha levels were adjusted for higher levels in females and with increasing age. Results: Adjusted mean sIL2Ra values of unaffected siblings, averaged within their families, were higher than controls (n = 14, one-tailed p = 0.027). There was no difference in sIL2Ralpha values between fathers or mothers and controls following regression for age and sex. Conclusion: Soluble interleukin 2 receptoralpha levels are increased in siblings of patients with schizophrenia. (C) 2002 Elsevier Science B.V. All rights reserved.Background: Several authors have reported increased soluble interleukin 2 receptor (sIL2Ralpha) concentrations in schizophrenia. The aim of this work was to examine serum sIL2Ra in the first degree relatives of patients with schizophrenia. Methods: We sampled 51 first degree relatives of patients with DSM IIIR schizophrenia. These relatives were unaffected by psychosis and included nine fathers, thirteen mothers, seventeen sisters and twelve brothers. They were compared to 126 controls who were not pregnant, had no known autoimmune disorder and no intercurrent illness. Neither the controls, nor their first degree relatives, suffered from a psychotic illness. Serum sIL2Ralpha was analysed using a commercial ELISA preparation (Quantikine sIL2Ralpha immunoassay - R and D Systems, Inc.). We used non-parametric Mann Whitney U test and Spearman correlation throughout. SIL2Ralpha levels were adjusted for higher levels in females and with increasing age. Results: Adjusted mean sIL2Ra values of unaffected siblings, averaged within their families, were higher than controls (n = 14, one-tailed p = 0.027). There was no difference in sIL2Ralpha values between fathers or mothers and controls following regression for age and sex. Conclusion: Soluble interleukin 2 receptoralpha levels are increased in siblings of patients with schizophrenia. (C) 2002 Elsevier Science B.V. All rights reserved.}},
  issn = {0920-99640920-9964},
   = {://WOS:000176404300004://WOS:000176404300004},
  source = {IRIS}
}
AUTHORSGaughran, F.,O'Neill, E.,Sham, P.,Daly, R. J.,Shanahan, F.
YEAR2002
MONTHAugust
JOURNAL_CODESchizophrenia Research
TITLESoluble interleukin 2 receptor levels in families of people with schizophrenia
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORD
VOLUME56
ISSUE3
START_PAGE235
END_PAGE239
ABSTRACTBackground: Several authors have reported increased soluble interleukin 2 receptor (sIL2Ralpha) concentrations in schizophrenia. The aim of this work was to examine serum sIL2Ra in the first degree relatives of patients with schizophrenia. Methods: We sampled 51 first degree relatives of patients with DSM IIIR schizophrenia. These relatives were unaffected by psychosis and included nine fathers, thirteen mothers, seventeen sisters and twelve brothers. They were compared to 126 controls who were not pregnant, had no known autoimmune disorder and no intercurrent illness. Neither the controls, nor their first degree relatives, suffered from a psychotic illness. Serum sIL2Ralpha was analysed using a commercial ELISA preparation (Quantikine sIL2Ralpha immunoassay - R and D Systems, Inc.). We used non-parametric Mann Whitney U test and Spearman correlation throughout. SIL2Ralpha levels were adjusted for higher levels in females and with increasing age. Results: Adjusted mean sIL2Ra values of unaffected siblings, averaged within their families, were higher than controls (n = 14, one-tailed p = 0.027). There was no difference in sIL2Ralpha values between fathers or mothers and controls following regression for age and sex. Conclusion: Soluble interleukin 2 receptoralpha levels are increased in siblings of patients with schizophrenia. (C) 2002 Elsevier Science B.V. All rights reserved.Background: Several authors have reported increased soluble interleukin 2 receptor (sIL2Ralpha) concentrations in schizophrenia. The aim of this work was to examine serum sIL2Ra in the first degree relatives of patients with schizophrenia. Methods: We sampled 51 first degree relatives of patients with DSM IIIR schizophrenia. These relatives were unaffected by psychosis and included nine fathers, thirteen mothers, seventeen sisters and twelve brothers. They were compared to 126 controls who were not pregnant, had no known autoimmune disorder and no intercurrent illness. Neither the controls, nor their first degree relatives, suffered from a psychotic illness. Serum sIL2Ralpha was analysed using a commercial ELISA preparation (Quantikine sIL2Ralpha immunoassay - R and D Systems, Inc.). We used non-parametric Mann Whitney U test and Spearman correlation throughout. SIL2Ralpha levels were adjusted for higher levels in females and with increasing age. Results: Adjusted mean sIL2Ra values of unaffected siblings, averaged within their families, were higher than controls (n = 14, one-tailed p = 0.027). There was no difference in sIL2Ralpha values between fathers or mothers and controls following regression for age and sex. Conclusion: Soluble interleukin 2 receptoralpha levels are increased in siblings of patients with schizophrenia. (C) 2002 Elsevier Science B.V. All rights reserved.
PUBLISHER_LOCATION
ISBN_ISSN0920-99640920-9964
EDITION
URL://WOS:000176404300004://WOS:000176404300004
DOI_LINK
FUNDING_BODY
GRANT_DETAILS